Pharmaceutical Interventions

Zepbound Hormonal Treatments Clinical Guidelines Wegovy Patient Reports GLP-1 Treatments

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

New oral drugs and cheaper generics are driving interest while cost, injection aversion, uncertain long‑term effects and high payer bills are prompting cautious prescribing and tighter employer coverage.